| Application no. and date | 11751300.2 (espacenet) (Federated) (European Patent Register), 20110302 | | Patent/reg. no. and date | DK/EP 2542079, 20140521 | | Publication date | 20130109 | | Priority no. and date | US 339375 P, 20100303 | | EP pub. no. and date |
EP 2542079 20130109 | | Effective date | | | Applicant/owner | Teva Pharmaceutical Industries Ltd., 5 Basel Street
P.O. Box 3190
49131 Petach-Tikva, IL | | Applicant ref. no. | P014506EPDK1 | | Inventor | BLAUGRUND, Eran, 94 Remez Street
76449 Rehovot, IL,
TARCIC, Nora, Migdal David 29/1
Modiin, IL,
KAYE, Joel, 14/5 Hazamir St
Netanya, IL | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/4704 (2006.01) , A61K 31/519 (2006.01) , A61P 19/02 (2006.01) | | Title | Behandling af reumatoid artritis med en kombination af laquinimod og methotrexat | | Int. application no. | US2011026885 | | Int. publication no. | WO2011109531 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
